Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MusclePharm Corp (OTCQB:MSLP)

4.94
Delayed Data
As of Jul 29
 -0.01 / -0.20%
Today’s Change
2.78
Today|||52-Week Range
14.20
-41.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-23.3M-19.0M-17.7M-13.8M
 
 
 
 
 
Depreciation171.6K475.3K709.0K2.0M
 
 
 
 
 
Total Other Cash Flow12.3M9.4M17.3M15.0M
 
 
 
 
 
Funds From Operations-10.9M-9.1M304.6K3.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-5.1M-8.4M10.3M7.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-5.8M-697.6K-10.0M-4.1M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-2.8M0.00
 
 
Decrease In Investments0.000.002.8M490.0K
 
 
 
Capital Expenditures-831.5K-924.2K-1.9M-4.1M
 
 
 
 
 
Fixed Asset Disposal0.00--17.7K2.0K
 
 
 
Other Investing - Uses0.00-41.2K-2.5M0.00
 
 
 
Other Investing - Sources0.000.001.0M2.5M
 
 
 
Net Cash Flow Investing-831.5K-965.3K-3.5M-1.6M
 
 
 
 
 
 
FinancingShort Term Borrowings-75.3K69.4K2.5M5.4M
 
 
 
 
 
Long Term Borrowings6.3M5.6M-7.5K0.00
 
 
 
 
Long Term Debt Reduction0.00-5.8M-4.4M-104.0K
 
 
 
 
Net Proceeds Stock Sale975.0K1.7M21.9M0.00
 
 
 
 
Common Preferred Redeemed0.00-461.0K-1.0M-3.9M
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing7.2M1.0M18.9M1.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash---7.9K-6.1K-52.0K
 
 
 
 
 
Net Change In Cash616.1K-651.9K5.4M-4.3M